Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Nifty 50 opened above 24,100, shifting the intraday structure. The 24,260 resistance is the next test. A break opens 24,350. The dip-buying zone sits at 24,170-24,210.
WD-40 posted record Q3 sales but faces margin pressure. FY2026 sales guidance set at $675M-$690M, homecare brands reclassified, $100M buyback authorized.
AMAT has fallen 20% in weeks as AI capex concerns mount. Alpha Score 68 signals moderate risk. The next catalyst is the quarterly report in late August. What would confirm or reverse the setup?
Grand Canyon Education's strong growth hasn't created a valuation edge. The stock prices in the upbeat outlook, leaving regulatory and competitive shifts as risks.
Micron dropped nearly 30% after a Q4 revenue guide came in $380M below consensus. The gap reflects an HBM capacity wall, not a demand shock. A Q4 beat in September is the next test.
A trader spent $24 million on a QQQ call spread that needs the Nasdaq 100 to hit an all-time high by July 31. The breakeven is near $750, less than $2 above the June high. Here is what the trade says about market conviction.
Camtek's next quarterly report will test whether its 30x earnings premium holds. The AI packaging boom is visible, but concentration risk is real.
Preferred Bank's July 22 Q2 call, with CEO Li Yu and management, will test loan growth, net interest margin, and credit quality for California-focused commercial lenders.
Jefferies sees FY2028 EPS of $30-$40 as Broadcom locks in Google TPU revenue through 2031 and adds an OpenAI custom chip deal, with $500B potential upside.
Calumet's business has improved, yet the stock's 60% rally leaves little upside. A Seeking Alpha analyst sees fair value near $18-$20, implying 10% downside.
Meta's Muse Spark 1.1 takes aim at OpenAI and Anthropic with stronger agentics, multistep reasoning, and a price advantage that could shift enterprise AI spending.
Tarsus Pharma's iRenix acquisition adds a device for Demodex blepharitis to complement Xdemvy. The slide deck outlines the strategy but leaves financial terms and launch timing for the next earnings call.
Nifty 50 sank 2.1% to 23,882 after Trump's Iran remarks. Analysts expect volatility to persist as global risk-off deepens. The sell-off was broad-based across sectors.
A merger arb skeptic made an exception for Caesars Entertainment. The analyst cited a rare asymmetric setup. The deal's regulatory and financing path now matters.
SpaceX slid below its $150 debut price for a second day after the Nasdaq 100 inclusion. Analyst ratings are mostly bullish; MoffettNathanson is neutral and CFRA recommends selling.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from ...
Quant Mid Cap Fund beat its benchmark over 3 and 6 months after years of lagging. Expert Rathore says don't judge recovery on recent returns alone—look at rolling returns, alpha, and risk-adjusted metrics.
SpaceX debt trades at junk yields while one analyst rates the stock a buy. The divergence shows how private markets price near-term cash stress against long-term optionality.
A previously bullish analyst now says Datadog lacks the durable moat needed for premium SaaS multiples. Alpha Score 71 reflects balanced risk-reward; Q1 earnings loom.
Trimble is shifting from hardware to software subscriptions, but the stock still trades like the old business. The next earnings report will test whether the market finally re-rates the company.
RBC Capital raised its price target on Rackspace Technology to $4 after a Q1 revenue beat and AMD partnership details. The stock has surged 569%. The AI cloud ramp starts late 2026.
IREN shares fell 30% after a sell rating linked to its Meta compute deal. The neocloud window is closing as large tech firms build their own capacity. Alpha Score 12/100.
Tvardi surged 48% after Phase 1 data showed its next-gen STAT3 inhibitor TTI-109 improved tolerability and hit target exposure. The results validate STAT3 as a druggable node.
Enlivex's 1-for-15 reverse split reduces outstanding shares from 252.5M to 16.8M. Shares fell 2.9% as the company adjusts its capital structure.
Nasdaq futures lead the decline Tuesday as AI valuations come under fresh scrutiny. Traders rotate into defensives. Treasury yields rise.
A Seeking Alpha analyst rates ON a Strong Buy, sees 30% upside from $97. The Alpha Score of 36 signals a mixed picture. What would confirm the thesis?
Emaar The Economic City's COO said industrial and tourism projects will strengthen financial performance in the coming years, as the company focuses on King Abdullah Economic City development.
Bulldog Investors, holding 3% of Runway Growth Finance, demands a larger buyback as the stock trades at a 55% discount to NAV. The activist may seek board seats if management does not act.
CHI's tech-heavy convertible portfolio creates a double risk: conversion value and bond floors both weaken in a selloff, amplified by the premium to NAV.
Bernstein downgraded Datadog to market-perform on Q4 caution. The stock fell 2.3% after the analyst raised the price target to $145 and cut the rating.